Is that a fair statement? After all, it’s not that long ago that DNDN was in the mid 4’s and now it’s one-third higher at around 6. High volatility is not surprising given the uncertainty about when—and what—the company is going to report for 9902a.
>>I'm puzzled, as REGN is up 50% from my purchase<<
I assumed that REGN was rising on the Lucentis coattails. REGN’s VEGF-Trap is the most similar AMD drug to Lucentis, mechanistically. As you know, REGN just started phase-1 with local administration (#msg-6872397).
I have no idea why CEGE has been strong lately. Regards, Dew
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.